Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2024-09-24 Interim / Quarterly Rep…
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
Selvita_raport_H1_2024_PL
Interim / Quarterly Report Classification · 100% confidence The document is a 'Skonsolidowany raport półroczny za H1 2024' (Consolidated Semi-Annual Report for H1 2024) for the Selvita Capital Group. It contains detailed financial statements, balance sheets, income statements, and management commentary for the first half of the fiscal year. As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report. H1 2024
2024-09-24 Polish
Selvita_raport_H1_2024_EN
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Consolidated H1 2024 Report' for Selvita Capital Group. It contains comprehensive financial statements, including consolidated balance sheets and profit and loss statements for the six-month period ending June 30, 2024. It includes management commentary, analysis of financial results, and detailed tables of financial data. As it covers a period shorter than a full fiscal year and contains substantive financial statements and analysis, it is classified as an Interim/Quarterly Report. H1 2024
2024-09-24 English
Consolidated Financial Statements IFRS Selvita 30.06.2024 ENG
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Condensed Consolidated Financial Statements' for the period ending 30/06/2024. It contains comprehensive financial statements (Statement of Comprehensive Income, Statement of Financial Position, etc.) and detailed explanatory notes. It is not an announcement or a summary, but the full interim report itself, fitting the definition of an Interim/Quarterly Report (IR). H1 2024
2024-09-24 English
1H2024 Raport z przeglądu_Selvita S.A. GK_translation
Audit Report / Information Classification · 99% confidence The document is explicitly titled 'Independent registered auditor's report on the review of the interim condensed consolidated financial statements'. It details a review conducted in accordance with ISRE 2410 for the period ending 30 June 2024. This content directly corresponds to the definition of an Audit Report/Information, which covers standalone audit reports and results of reviews, distinguishing it from a full Annual Report (10-K) or a general Interim Report (IR). Therefore, the appropriate code is AR. H1 2024
2024-09-24 English
1H2024 Raport z przeglądu_Selvita S.A. GK
Audit Report / Information Classification · 98% confidence The document is titled "Raport niezależnego biegłego rewidenta z przeglądu śródrocznego skróconego skonsolidowanego sprawozdania finansowego" (Independent auditor's report on the review of the condensed interim consolidated financial statements). It explicitly covers the period ending June 30, 2024, and references International Accounting Standard 34 (Interim Financial Reporting). This content—a formal report from an auditor regarding an interim financial statement review—fits the definition of an Audit Report / Information (AR), which covers standalone audit reports and results of internal/regulatory stress tests, distinguishing it from a full Annual Report (10-K) or a general Interim Report (IR). The document length is short (3263 chars), but it is the report itself (the auditor's conclusion), not merely an announcement of its publication. H1 2024
2024-09-24 Polish
1H2024 Raport z przeglądu_Selvita S.A. (JSF)_translation
Audit Report / Information Classification · 99% confidence The document is explicitly titled 'Independent registered auditor's report on the review of the condensed financial statements' for the period ending June 30, 2024. This document contains the auditor's conclusion based on a review of interim financial information, which aligns perfectly with the definition of an Audit Report / Information (AR). It is not a full Annual Report (10-K) as it covers only the first half of the year (interim) and is specifically the auditor's opinion, not the full management discussion and analysis or comprehensive financial statements package. H1 2024
2024-09-24 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.